Transcranial Direct Current Stimulation to Enhance Cognition in Mild Cognitive Impairment

The study will examine whether the effects of computerized brain training are enhanced when training is combined with mild brain stimulation in patients with mild cognitive impairment. We hypothesize that this combination will produce greater improvements in cognitive functioning than computerized brain training alone.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Mild Cognitive Impairment Cognition Disorders Cognitive Dysfunction Mental Disorders Neurocognitive Disorders

Age range

60 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Black Dog Institute

Sydney, New South Wales, 2031, Australia

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Aged 60 - 85 years.
Meet diagnostic criteria for amnestic mild cognitive impairment.

Exclusion criteria

Inability to provide informed consent.
Concurrent medication likely to affect mental performance.
Current substance use or dependence in last 3 months.
Current active psychiatric or neurological condition

Treatment and study plan

Transcranial Direct Current Stimulation

Device

Primary outcomes

California Verbal Learning Test II

Time frame: Post treatment

Sponsors and collaborators

Lead sponsor

The University of New South Wales

Other

Registry information

Important dates

Study start: 2013
Primary completion: 2018
Study completion: 2019
First posted: Jul 31, 2012
Registry last updated: Feb 7, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed